Biochemical and biophysical properties of the core-binding factor alpha 2 (AML1) DNA-binding domain

被引:53
|
作者
Crute, BE
Lewis, AF
Wu, ZN
Bushweller, JH
Speck, NA
机构
[1] DARTMOUTH COLL,SCH MED,DEPT CHEM,HANOVER,NH 03755
[2] DARTMOUTH COLL,SCH MED,DEPT BIOCHEM,HANOVER,NH 03755
[3] DARTMOUTH COLL,SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH 03755
关键词
D O I
10.1074/jbc.271.42.26251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Runt domain is the DNA-binding domain defining a small family of transcription factors that are involved in important developmental processes. Developmental pathways controlled by Runt domain proteins include sex determination, neurogenesis, segmentation, and eye development in Drosophila and hematopoiesis in mammals. In addition to binding DNA, the Runt domain also mediates heterodimerization with another subunit called the core-binding factor beta (CBF beta) subunit. In this study we overexpress the Runt domain from the mouse CBF alpha 2 (AML1) protein in Escherichia coli, and purify it from the insoluble fraction. We determine the equilibrium constants for Runt domain binding to two different DNA sequences by surface plasmon resonance technology. Circular dichroism spectroscopy demonstrates that the Runt domain is a folded beta-domain with essentially no alpha-helical content. The single tryptophan residue in the CBF alpha 2 Runt domain at amino acid 79 is shown by tryptophan fluorescence spectroscopy to reside in a polar environment. Finally, we demonstrate that ATP can be UV cross-linked to the Runt domain and that ATP binding is sensitive to an amino acid substitution in the putative Kinase-1a motif (P-loop).
引用
收藏
页码:26251 / 26260
页数:10
相关论文
共 50 条
  • [1] The core-binding factor (CBF) beta subunit is essential for CBF alpha 2 (AML1) function in vivo.
    Wang, Q
    Stacy, T
    Miller, JD
    Lewis, AF
    Gu, TL
    Huang, X
    Bushweller, JH
    Bories, JC
    Alt, FW
    Ryan, G
    Liu, PP
    WynshawBoris, A
    Binder, M
    MarinPadilla, M
    Sharpe, AH
    Speck, NA
    BLOOD, 1996, 88 (10) : 1147 - 1147
  • [2] Crystallization and preliminary studies of the DNA-binding runt domain of AML1
    Bäckström, S
    Huang, SH
    Wolf-Watz, M
    Xie, XQ
    Härd, T
    Grundström, T
    Sauer, UH
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2001, 57 : 269 - 271
  • [3] Overexpression, purification, and biophysical characterization of the heterodimerization domain of the core-binding factor β subunit
    Huang, XM
    Crute, BE
    Sun, CH
    Tang, YY
    Kelley, JJ
    Lewis, AF
    Hartman, KL
    Laue, TM
    Speck, NA
    Bushweller, JH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) : 2480 - 2487
  • [4] Auto-inhibition and partner proteins, core-binding factor β (CBFβ) and Ets-1, modulate DNA finding by CBFα2 (AML1)
    Gu, TL
    Goetz, TL
    Graves, BJ
    Speck, NA
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) : 91 - 103
  • [5] Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements
    Lavallee, Vincent-Philippe
    Cendron, Patrick
    Boucher, Genevieve
    Lemieux, Sebastien
    Armstrong, Richard Neil
    Boivin, Isabel
    Sauvageau, Guy
    Hebert, Josee
    BLOOD, 2015, 126 (23)
  • [6] Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor α2
    Goetz, TL
    Gu, TL
    Speck, NA
    Graves, BJ
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) : 81 - 90
  • [7] TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL
    Morrow, M.
    Samanta, A.
    Kioussis, D.
    Brady, H. J. M.
    Williams, O.
    ONCOGENE, 2007, 26 (30) : 4404 - 4414
  • [8] Structural insights into the mechanism by which the core-binding factor β subunit (CBFβ) enhances DNA-binding by the CBFα subunit.
    Tang, YY
    Huang, X
    Berardi, M
    Yan, J
    Shi, J
    Davis, AL
    Speck, NA
    Bushweller, JH
    BLOOD, 1999, 94 (10) : 683A - 683A
  • [9] TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL
    M Morrow
    A Samanta
    D Kioussis
    H J M Brady
    O Williams
    Oncogene, 2007, 26 : 4404 - 4414
  • [10] NMR structural and biophysical characterization of the beta subunit of core-binding factor.
    Bushweller, JH
    Huang, XM
    Speck, NA
    BLOOD, 1997, 90 (10) : 171 - 171